People
Ryvu Therapeutics names new chief business officer
27 April 2021 -

Ryvu Therapeutics (WSE: RVU), a Poland-based clinical-stage drug discovery and development company, announced on Monday that it has named Vatnak Vat-Ho as its new chief business officer.

In the new role, Vat-Ho will be responsible for a wide scope of corporate and business development activities at Ryvu, including strategic positioning, partnering discussions, alliance management as well as investor interactions.

Vat-Ho has around 20 years of professional experience including pharma, biotech and capital markets expertise. He spent the first 10 years of his professional career in various investment banks and global equity healthcare funds, later moving to the pharma and biotech industry. He has served in various roles at Pfizer. He has also served as vice president, Business Development at Affimed Inc.

Login
Username:

Password: